KLK3 and posterior cortical atrophy: 4Kscore® Test (OPKO Health, Miami, FL, USA) was developed by Vickers et al. in 2008, using a large cohort of men from the Gothenburg arm of the European Randomized PCa Screening Study (ERSPC), and is based on a logistic model that considers four forms of kallikrein (total PSA, free PSA, intact PSA, and hK2), in order to accurately predict the presence of PCa in men with a PSA 3.0 ng/mL or higher (AUC 0.84) [21].